Natera, Inc. (NTRA)
Nasdaq: NTRA · Services-Medical Laboratories · Austin, TX · filing with the SEC since 2014
Grade6.6
◀ Past 5.8● Present 6.5▶ Future 7.5
The company now
Natera, Inc. is classed by the SEC under Services-Medical Laboratories (industry code 8071), based in Austin, TX. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $2.3 billion and a loss of $208 million (its filed statements).
From its filings and filed figures; the desk's account of it is not written yet.
Where the revenue comes from
fiscal 2025, as filedRevenue by product, fiscal 2025
| Product | Fiscal 2025 | Fiscal 2024 | Share of revenue |
|---|---|---|---|
| Product | $2.30B | $1.69B | 99.6% |
| Licensing and Other | $10.3M | $11.8M | under 1% |
Revenue by region, fiscal 2025
| Region | Fiscal 2025 | Fiscal 2024 | Share of revenue |
|---|---|---|---|
| United States | $2.26B | $1.66B | 98.2% |
| Europe, Middle East, India, and Africa | $24.5M | $23.9M | 1.1% |
| Americas, excluding U.S. | $9.4M | $6.6M | under 1% |
| Asia Pacific and Other | $8.0M | $8.7M | under 1% |
As tagged in its annual report (Form 10-K, filed Feb 27, 2026 ↗), read from the SEC's financial statement data sets. The year before is the figure the record holds for the prior fiscal year.
The desk's written account of this company, its Past, Present and Future, is not on file yet.
How the company works
The desk has not read this company's annual report yet.
The record in brief
The desk has not written this company's report yet.